LNTH today
$101.25-$0.35 (-0.34%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bearish
1 hourBearish
15 minBearish
5 minConsolidating
Daily trend turns up above $109.48
Key levels
Resistance$102.90
Resistance$101.27
Support$100.40
Support$99.59
Latest news & SEC filings
DealPharmaLogic buys Lantheus CDMO unit and Springfield plant
DealPharmaLogic Holdings to buy Lantheus CDMO business and Springfield plant
All LNTH news →About Lantheus
Lantheus is a radiopharmaceutical company that develops and sells diagnostic imaging agents and cancer therapies. Its main products include PYLARIFY for prostate cancer imaging, DEFINITY for echocardiograms, and Neuraceq for Alzheimer's disease imaging. The company serves hospitals, imaging centers, and government facilities, primarily in the United States, with additional operations in Europe, Canada, Australia, and Asia.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
Lantheus Holdings, Inc. (LNTH)
What Is the Price Target for LNTH?
SEPT Low Target
$102.50
SEPT Mid Target
$112.00
SEPT High Target
$129.00
Analyst Consensus
$112.00
Is LNTH a Buy or Sell Right Now?
Thesis
- •Revenue growing 0.5% YoY with STRONG trend — consistent growth.
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for LNTH.
Start Free Trial →Is LNTH Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$98.40
58
Moat Score
NARROW
4/9
Piotroski Score
5.5
Altman Z-Score
What Is Smart Money Doing with LNTH?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
BUYING
4 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Marshall Robert J. Jr. | officer | Sale | 721 | $73K | Aug 31, 2026 |
| McHugh Julie | director | Buy | 4,137 | - | May 14, 2026 |
| Morrow Phuong Khanh | director | Buy | 4,137 | - | May 14, 2026 |
| Maeusli Heinz Christoph | director | Buy | 4,137 | - | May 14, 2026 |
| LENO SAM R | director | Buy | 4,137 | - | May 14, 2026 |
| Pruden Gary J | director | Buy | 4,137 | - | May 14, 2026 |
| Baylor-Henry Minnie | director | Buy | 4,137 | - | May 14, 2026 |
| Ber Gerard | director | Buy | 4,137 | - | May 14, 2026 |
| Thrall James H | director | Buy | 4,137 | - | May 14, 2026 |
| EASTLAND JULIA MARIE | director | Buy | 4,137 | - | May 14, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →LNTH Growth Story
Revenue YoY
0.5%
3yr Revenue CAGR
18.1%
EPS Growth YoY
-21.79%
FCF Growth YoY
N/A%
Revenue Trend
STRONG
Dark Pool Trades for LNTH
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for LNTH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:37 | $101.25 | 1,866 | $$189K | BUY |
| 21:00:12 | $101.25 | 3,025 | $$306K | BUY |
| 21:00:00 | $101.25 | 14,861 | $$1.5M | SELL |
| 20:57:07 | $101.19 | 2,100 | $$212K | MIDPOINT |
| 20:55:46 | $101.16 | 1,600 | $$162K | MIDPOINT |
5 dark pool trades shown · $$2.4M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Lantheus Holdings, Inc. (LNTH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →LNTH — frequently asked questions
What is LNTH stock price today?
Lantheus Holdings, Inc. (LNTH) is at $101.25, down 0.34% (-$0.35) at the Nov 12, 2026 close.
Why is LNTH stock moving today?
Latest LNTH news — Nov 9, 2026: PharmaLogic buys Lantheus CDMO unit and Springfield plant · Nov 9, 2026: PharmaLogic Holdings to buy Lantheus CDMO business and Springfield plant
What is the LNTH price target?
The average analyst price target for LNTH is $112.00, ranging from $103 to $129, based on 6 analysts. Latest: Mizuho downgrade on Oct 13, 2026.
What do analysts rate LNTH?
Analyst ratings for LNTH: 2 Buy, 8 Hold, 0 Sell — consensus Hold.
Did LNTH beat earnings?
LNTH last reported on Nov 5, 2026: EPS $0.33 vs $1.23 expected — a miss of 73.2%.
What is LNTH's P/E ratio?
LNTH trades at a P/E of 24.6 vs a Healthcare average of 17.1.
Does LNTH pay a dividend?
LNTH does not currently pay a dividend.
How much debt does LNTH have?
Lantheus Holdings, Inc. reported $571M of debt and $684M of cash (Sep 30, 2026).
What are LNTH support and resistance levels?
Support: $100.40, $99.59, $98.81. Resistance: $101.27, $102.90, $104.00.
What are insiders doing with LNTH?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on LNTH?
Nov 9, 2026: PharmaLogic buys Lantheus CDMO unit and Springfield plant · Nov 9, 2026: PharmaLogic Holdings to buy Lantheus CDMO business and Springfield plant